AI analysis of one-year CT changes predicts disease progression and survival in fibrotic interstitial lung disease.
Key Details
- 1Researchers at National Jewish Health used an AI-based tool to detect subtle increases in lung fibrosis on serial CT scans.
- 2A 5% or more increase in fibrosis score over one year doubled the risk of death or lung transplant for patients.
- 3AI-derived fibrosis changes predicted steeper lung function decline, especially in patients with less severe baseline disease.
- 4The deep learning method, data-driven textural analysis (DTA), provided precise, objective fibrosis quantification.
- 5Results were validated with data from the Pulmonary Fibrosis Foundation Patient Registry, demonstrating generalizability.
- 6Quantitative CT analysis could be used for trial endpoints and real-world risk stratification.
Why It Matters
This study demonstrates the clinical potential of deep learning-based CT quantification for early risk identification and outcome prediction in fibrotic lung disease. It supports wider use of imaging AI as an objective, reproducible tool for prognosis and treatment decision-making in complex pulmonary disorders.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.